Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 18, Issue 11, Pages 1081-1088
Publisher
Wiley
Online
2016-06-06
DOI
10.1111/dom.12698
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucodynamics of long-acting basal insulin peglispro compared with insulin glargine at steady state in patients with type 1 diabetes: substudy of a randomized crossover trial
- (2016) L. A. Morrow et al. DIABETES OBESITY & METABOLISM
- Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials
- (2016) Henry Ginsberg et al. DIABETES OBESITY & METABOLISM
- Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial
- (2016) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial
- (2015) An Tang et al. DIABETES CARE
- Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
- (2015) John B. Buse et al. DIABETES CARE
- Performance of an Electronic Diary System for Intensive Insulin Management in Global Diabetes Clinical Trials
- (2015) Edward J. Bastyr et al. Diabetes Technology & Therapeutics
- Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects
- (2014) Robert R. Henry et al. DIABETES CARE
- Single-dose pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 in healthy subjects
- (2014) Vikram P. Sinha et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Estimation of group means when adjusting for covariates in generalized linear models
- (2014) Yongming Qu et al. PHARMACEUTICAL STATISTICS
- Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
- (2013) M. C. Moore et al. DIABETES
- Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes
- (2013) M. Blanco et al. DIABETES & METABOLISM
- Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus
- (2013) V. P. Sinha et al. DIABETES OBESITY & METABOLISM
- The Effect of Adjusting for Baseline Hypoglycemia when Analyzing Hypoglycemia Data: A Systematic Analysis of 15 Diabetes Clinical Trials
- (2013) Junxiang Luo et al. Diabetes Technology & Therapeutics
- Analysis of hypoglycemic events using negative binomial models
- (2013) Junxiang Luo et al. PHARMACEUTICAL STATISTICS
- Review article: drug-induced liver injury - its pathophysiology and evolving diagnostic tools
- (2011) J. S. Au et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors
- (2009) H. Hauner et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- General Multistage Gatekeeping Procedures
- (2008) Alex Dmitrienko et al. BIOMETRICAL JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search